AMA Urges 340B Transparency, Expansion Of Program To More Providers
The American Medical Association is pushing for 340B reforms that would increase transparency in the drug pricing program, expand the Health Resources and Services Administration’s authority over 340B and extend program eligibility to all practices that show a commitment to serving low-income patients.
